1. Nonmuscle Tissues Contribution to Cancer Cachexia
   Josep M. Argilés et al, 2015, Mediators of Inflammation CrossRef
2. Increased hypoxia-inducible factor-1α in striated muscle of tumor-bearing mice
   Raymond D. Devine et al, 2017, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
3. Subcutaneous Ehrlich Ascites Carcinoma mice model for studying cancer-induced cardiomyopathy
   Sneha Mishra et al, 2018, Scientific Reports CrossRef
4. Evaluation of cancer-derived myocardial impairments using a mouse model
   Yoshihiro Miyagawa et al, 2020, Oncotarget CrossRef
5. Evaluation of selected antidiabetics in cardiovascular complications associated with cancer cachexia
   Vivek R. Bora et al, 2023, Molecular and Cellular Biochemistry CrossRef
6. Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: alterations in sarcomeric and mitochondrial protein expression
   Angie M. Y. Shum et al, 2018, Oncotarget CrossRef
7. Cardiac Complications: The Understudied Aspect of Cancer Cachexia
   Vivek Bora et al, 2022, Cardiovascular Toxicology CrossRef
8. Mechanism of Skeletal Muscle Atrophy Using a Mice Cancer Cachexia Model
   Takuya Mori et al, 2022, Physical Therapy and Research in Patients with Cancer CrossRef
9. Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene
   Michele Ferrara et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
10. The pathophysiology of cancer‐mediated cardiac cachexia and novel treatment strategies: A narrative review
    Louisa Tichy et al, 2023, Cancer Medicine CrossRef
11. How progressive cancer endangers the heart: an intriguing and underestimated problem
    Simonetta Ausoni et al, 2020, Cancer and Metastasis Reviews CrossRef
12. Tumor burden negatively impacts protein turnover as a proteostatic process in noncancerous liver, heart, and muscle, but not brain
    Jacob L. Brown et al, 2021, Journal of Applied Physiology CrossRef
13. Cardiac Remodeling in Cancer-Induced Cachexia: Functional, Structural, and Metabolic Contributors
    Michael P. Wiggs et al, 2022, Cells CrossRef
14. Systemic study of selected histone deacetylase inhibitors in cardiac complications associated with cancer cachexia
    Vivek Bora et al, 2022, Canadian Journal of Physiology and Pharmacology CrossRef
15. Therapy-naïve malignancy causes cardiovascular disease: a state-of-the-art cardio-oncology perspective
    Leslie M. Ogilvie et al, 2024, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
16. Effects of prostate cancer and exercise training on left ventricular function and cardiac and skeletal muscle mass
    Dryden R. Baumfalk et al, 2019, Journal of Applied Physiology CrossRef
17. Leucine and Its Importance for Cell Signalling Pathways in Cancer Cachexia-Induced Muscle Wasting
    Andre Gustavo Oliveira et al, 2020, Muscle Cells - Recent Advances and Future Perspectives CrossRef
18. Pathogenetic mechanisms of development of myocardial pathology in patients with malignant tumors: the current state of the problem
    A. G. Obrezan et al, 2020, Kardiologiia CrossRef